Senti Biosciences is trading 10.5% up today at $0.38 amid a modest rebound in beaten-down biotech names and a generally risk-on tape.
- There are no new company-specific filings, press releases, or analyst calls tied directly to the move this morning.
- Today’s strength appears to be driven by the low-priced biotech participating in sector-wide gains following a period of recent weakness.